The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Risk of hip fracture in patients with a history of schizophrenia
Open accessAbstract
Background: There is evidence of an association between decreased bone mineral density schizophrenia, and prolactin-raising antipsychotic medication. However, it is not known whether this is clinically significant. Aims: To investigate whether patients with a history of schizophrenia are at increased risk of hip fracture. Method: In a case-control study, we compared cases of ‘hip fracture’ on the General Practice Research Database (n=16 341) with matched controls (n=29 889). Results: Hip fracture was associated with schizophrenia (OR=1.73; 95% CI 1.32-2.28), and prolactin-raising antipsychotics (OR=2.6; 95% CI 2.432.78), in the univariate analysis. In the multivariate analysis, prolactin-raising antipsychotics were independently associated with hip fracture but schizophrenia was not. A significant interaction between gender and antipsychotics was found in the association with hip fracture (P=0.042); OR=2.12 (95% C11.73-2.59)for men, OR=l.93 (95% C11.78-2.10) for women. Conclusions: The association between prolactin-raising antipsychotic medication and hip fracture may have serious implications for public health. Mental health service patients may require preventive measures including dietary and lifestyle advice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other studies (506-510) have found significant increases (OR=1.2-2.6) in the risk of fractures associated with AP.”
From Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care (2011) · cites this paper as [506]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Use of Inhaled Corticosteroids and Risk of Fractures
van Staa, T. P., Leufkens, H. G. M., & Cooper, C. C. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.3.581 · Cited by 1,297
Kannus, P., Parkkari, J. P., Sievänen, H., Heinonen, A. O., VUORI, I. M., & Järvinen, M. (1996) · Bone · doi:10.1016/8756-3282(95)00381-9 · Cited by 952
Endogenous Hormones and the Risk of Hip and Vertebral Fractures among Older Women
Cummings, S. R., Browner, W. S., Bauer, D. C., Stone, K. L., Ensrud, K. E., Jamal, S. A., & Ettinger, B. B. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809103391104 · Cited by 660
The Treatment of Unrelated Disorders in Patients with Chronic Medical Diseases
Redelmeier, D. A., Tan, S. H., & Booth, G. L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805213382106 · Cited by 634
The UK General Practice Research Database
Walley, T., & Mantgani, A. (1997) · The Lancet · doi:10.1016/s0140-6736(97)04248-7 · Cited by 624
Jenkins, R., Lewis, G., Bebbington, P., Brugha, T. S., Farrell, M., GILL, B., & Meltzer, H. (1997) · Psychological Medicine · doi:10.1017/s0033291797005308 · Cited by 427
Morbidity and Rate of Undiagnosed Physical Illnesses in a Psychiatric Clinic Population
Koranyi, E. K. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780040056006 · Cited by 409
Causes and Consequences of the Gender Difference in Age at Onset of Schizophrenia
Häfner, H., der Heiden, W. A., Behrens, S., Gattaz, W. F., Hambrecht, M., Loffler, W., Maurer, K., Munk‐Jørgensen, P., Nowotny, B., Riecher‐Rössler, A., et al. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033317 · Cited by 333
Antipsychotic Drugs: A New Risk Factor for Osteoporosis in Young Women With Schizophrenia?
O'Keane, V., & Meaney, A. M. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000150223.31007.e0 · Cited by 307
Cumming, R. G., Nevitt, M. C., & Cummings, S. R. (1997) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a017956 · Cited by 296
Flagged first, then by citations
Research works printed but not linked: 1
- 1978, International Statistical Classification of Diseases and Related Health Problems
Cited by
Sorted by citations
Items 101–158 of 158
Avgerinou, C., Walters, K. R., Bazo‐Alvarez, J. C., Osborn, D., West, R. M., Clegg, A. P., & Petersen, I. (2024) · British Journal of General Practice · doi:10.3399/bjgp.2024.0055 · Cited by 10
“21 A 2007 UK case–control study using data from General Practice Research Database found that prolactin-raising antipsychotics were independently associated with hip fracture, but schizophrenia was not.”
Adverse skeletal effects of drugs – beyond Glucocorticoids
O’Sullivan, S., & Grey, A. B. (2014) · Clinical Endocrinology · doi:10.1111/cen.12549 · Cited by 9
“[110,111] Proposed mechanisms by which antipsychotic agents cause reduced BMD are by inducing hyperprolactinaemia and thereby hypogonadism, by a direct effect on bone metabolism or by increasing the risk of falls.”
BackgroundBruce, L. J., Pizzirani, B., Cox), R. G. (., Quarmby, T., O’Donnell, R., Strickland, D. L., & Skouteris, H. (2019) · Children and Youth Services Review · doi:10.1016/j.childyouth.2019.05.034 · Cited by 10
Higher incidence of hip fracture in newly diagnosed schizophrenic patients in Taiwan
Lai, S., Lin, C., & Liao, K.-F. (2013) · Libyan Journal of Medicine · doi:10.3402/ljm.v8i0.20911 · Cited by 10
“Evidence has shown that many factors are related to increased risk of hip fracture, but psychiatric diseases are not confirmatory (2, 3).”
BackgroundEdinoff, A. N., Nix, C. A., Fort, J. M., Kimble, J., Guedry, R., Thomas, G., Cornett, E. M., Kaye, A. M., & Kaye, A. D. (2021) · Psychiatry International · doi:10.3390/psychiatryint3010003 · Cited by 10
Effect of age and disease on bone mass in Japanese patients with schizophrenia
Sugawara, N., Yasui‐Furukori, N., Umeda, T., Tsuchimine, S., Fujii, A., Sato, Y., Saito, M., Furukori, H., Danjo, K., Matsuzaka, M., et al. (2012) · Annals of General Psychiatry · doi:10.1186/1744-859x-11-5 · Cited by 9
“It has previously been shown that patients taking antipsychotic medications are at greater risk for bone fractures [1].”
BackgroundMatei, V. P. (2018) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2018.483 · Cited by 8
“Longterm hyperprolactinemia may induce a state of chronic hypogonadism, which may increase the risk for osteoporosis and bones fractures (14).”
BackgroundFunctional Outcomes of Patients with Schizophrenia After Hip Fracture Surgery
Ng, J. P. H., Ho, S. W. L., Yam, M. G. J., & Tan, T. L. (2021) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.20.01652 · Cited by 8
Risk of hospitalised falls and hip fractures in working age adults receiving mental health care
Romano, E., Ma, R., Perera, G., Stewart, R. J., Tsamakis, K., Solmi, M., Vancampfort, D., Firth, J., Stubbs, B., & Mueller, C. (2021) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2021.07.006 · Cited by 8
“Working age adults (i.e., adults of an age at which people are typically engaged in work) with depression and schizophrenia also have reduced hip bone mineral density (BMD) and higher risk of osteoporosis [22,23], both strong predictors of fractures [12,19].”
BackgroundChanges in biomarkers of bone turnover in an aripiprazole add-on or switching study
Lodhi, R. J., Masand, S., Malik, A., Shivakumar, K., McAllister, V., O’Keane, V., Young, L. C., Heald, A. H., Sherwood, R. A., & Aitchison, K. J. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2015.12.007 · Cited by 8
Manavi, B. A., Corney, K. B., Mohebbi, M., Quirk, S. E., Stuart, A. L., Pasco, J. A., Hodge, J. M., Berk, M., & Williams, L. J. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02884-1 · Cited by 8
Esquizofrenia y su asociación con enfermedades médicas crónicas
Orellana, G., Rodríguez, M., González, N., & Durán, E. (2017) · Revista médica de Chile · doi:10.4067/s0034-98872017000801047 · Cited by 9
Shen, S., Liu, Y., Qiu, H., Tsai, K., Wu, H., Liang, W., Shu, M., & Chou, F. H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221948 · Cited by 7
Characterization of Hip Fractures Among Adults With Schizophrenia in Ontario, Canada
Ansari, H., Jaglal, S. B., Cheung, A. M., & Kurdyak, P. A. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.10550 · Cited by 6
Antipsychotic medication use and fracture: a case–control study
Manavi, B. A., Stuart, A. L., Pasco, J. A., Hodge, J. M., Weerasinghe, D. K., Samarasinghe, R. M., & Williams, L. J. (2023) · Scientific Reports · doi:10.1038/s41598-023-40762-w · Cited by 7
“Howard et al. 16 conducted a case–control study investigating the association between schizophrenia and hip fracture, using data from the General Practice Research Database.”
BackgroundMethodResultInfluentialThe Association Between Antipsychotics and Bone Fragility: An Updated Comprehensive Review
Mercurio, M., Spina, G., Galasso, O., Gasparini, G., Segura‐Garcìa, C., Fazio, P. D., & de Filippis, R. (2024) · Diagnostics · doi:10.3390/diagnostics14232745 · Cited by 9
“Additionally, the impact on prolactin levels has been explored [33], with evidence suggesting that long-term AP treatment in patients suffering from schizophrenia reduces BMD [35], raising the risk of osteoporosis [36,37].”
van der Leeuw, C., Peeters, S. C. T., Domen, P. A. E., van Kroonenburgh, M. J. P. G., van Os, J., Marcelis, M. C., & (G.R.O.U.P.), G. R. A. O. I. P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136320 · Cited by 5
Chiu, H., Yang, N.-P., Renn, J.-H., Chang, N., Chan, C., Chi-Yu, C., Yu, I.-L., & Hsu, J. (2013) · Journal of Orthopaedic Science · doi:10.1007/s00776-013-0365-6 · Cited by 5
“28), and a significant interaction between gender and antipsychotics was found in the association with hip fracture [10].”
BackgroundRisk of hip fracture in patients with a history of schizophrenia
Talbott, J. A. (2008) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)70724-2 · Cited by 5
Managing the risks associated with physical intervention: a discussion paper
Hollins, L., & Stubbs, B. (2011) · The British Journal of Forensic Practice · doi:10.1108/14636641111190015 · Cited by 4
Uygur, M., & Dinzeo, T. J. (2021) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2021.102760 · Cited by 3
Li, D., Yeh, T., Tsai, S., Chen, T., Liang, C., & Chen, M. (2023) · The European Journal of Psychiatry · doi:10.1016/j.ejpsy.2023.100224 · Cited by 2
Impact of Hyperprolactinaemia on the General Health of Patients with Schizophrenia
Wildgust, H. J., & Kohen, D. (2008) · Modern problems of pharmacopsychiatry/Modern trends in pharmacopsychiatry · doi:10.1159/000189779 · Cited by 2
Hiperprolactinemia y tratamiento antipsicótico. Manifestaciones clínicas y manejo
Rubio‐Abadal, E., & Usall, J. (2013) · Psiquiatría Biológica · doi:10.1016/j.psiq.2013.06.011 · Cited by 2
Prescriptions d'antipsychotiques chez l'enfant et l'adolescent
Bonnot, O., Consoli, A., & Cohen, D. (2011) · Encyclopédie médico-chirurgicale. Psychiatrie · doi:10.1016/s0246-1072(11)53146-3 · Cited by 2
Bone turnover markers in medicamentous and physiological hyperprolactinemia in female rats
Radojković, D., Pesic, M., & Ristić, T. (2014) · Vojnosanitetski pregled · doi:10.2298/vsp1406559r · Cited by 2
“J Bone Miner Res 1995; 10(9): 1312 20.”
BackgroundInfluentialHyperprolactinaemia and psychotropics: endocrine effects and treatment
Jose, B., & George, S. (2014) · British Journal of Hospital Medicine · doi:10.12968/hmed.2014.75.5.264 · Cited by 2
“Patients with mental illness are at higher risk for bone mineral loss irrespective of treatment (Howard et al, 2007).”
BackgroundEvaluation of the link between chronic antipsychotic use and osteoporosis
Downs, R., & Mathys, M. L. (2013) · Mental Health Clinician · doi:10.9740/mhc.n166823 · Cited by 2
Complications of neuroleptic hyperprolactinaemia
Mazo, G. E., & Николаевна, Г. Л. (2018) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2018-2-104-108 · Cited by 2
Does clozapine really affect bone mineral density? An experimental study
Aydın, B. K., Safalı, S., Aydın, M., Eğilmez, Ü., Cebeci, H., Çelik, M., & Abdülrezzak, Ü. (2021) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-021-02695-w · Cited by 2
Ma, R., Romano, E., Davis, K. A. S., Stewart, R. J., Ashworth, M. J., Vancampfort, D., Gaughran, F., Stubbs, B., & Mueller, C. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.01.005 · Cited by 2
Psychological structure of alexithymic space in patients with cardiovascular diseases
Brel, E. Y., Bokhan, N. A., & Stoyanova, I. Y. (2018) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2018-2-90-96 · Cited by 2
Comparison of Serum Zinc Levels between Patients with Schizophrenia and Healthy Individuals
Kamkar, M. Z., Khaboshan, F. S., & Marjani, A. (2020) · Journal of Clinical and Basic Research · doi:10.52547/jcbr.4.3.34 · Cited by 2
Buckley, P. F., & Foster, A. E. (2014) · Springer eBooks · doi:10.1007/978-3-7091-0715-7_4 · Cited by 2
Inoue, Y., Tokushige, A., Kinjyo, T., & Ueda, S. (2024) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.195 · Cited by 1
Ansari, H., Fung, K., Cheung, A. M., Jaglal, S. B., Bogoch, E. R., & Kurdyak, P. A. (2024) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2024.05.010 · Cited by 2
Hyperprolactinaemia in the context of psychiatry
Romain, K., Fynes-Clinton, S., Harmer, D., & Kumar, M. T. (2020) · BJPsych Advances · doi:10.1192/bja.2020.36 · Cited by 1
A Brief Guide to Medications for Psychosis
Harris, A. W. F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815012-2.00023-7 · Cited by 1
Tejón, S. G., Jato, M. I., Martin, M., Prats‐Uribe, A., Real, J., & Martín‐Lopez, L. M. (2021) · Atención Primaria · doi:10.1016/j.aprim.2021.102171 · Cited by 1
van der Leeuw, C. (2015) · doi:10.26481/dis.20150623cl · Cited by 1
THU0383 Osteoporosis in Epilepsy and Multiple Sclerosis Patients.
SLOUMA, M., Sahli, H., Rekik, S., Choeur, E., Meddeb, N., Elleuch, M., & Sallami, S. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-eular.911 · Cited by 1
Velayudhan, L., & Gangadhar, B. N. (2007) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670701635033 · Cited by 1
“systems [1], there has been no report of any associated”
Melkersson, K. I. (2007) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.849 · Cited by 1
Гиперпролактинемия,ассоциированная с приемом нейролептиков
Yunilaynen, O. A., & Владимирович, Д. И. (2013) · Социальная и клиническая психиатрия
Population-based studies on risk of fracture in patients with neurological disorders
Pouwels, S. (2014) · Utrecht University Repository (Utrecht University)
Hyperprolactinaemia Associated with Antipsychotic Medications
Fitzgerald, P., & Dinan, T. G. (2008) · Modern problems of pharmacopsychiatry/Modern trends in pharmacopsychiatry · doi:10.1159/000189778
Prolactin and Schizophrenia, an Evolving Relationship
Chris, J., & Pendlebury, J. (2011) · InTech eBooks · doi:10.5772/23484
“Certainly the data on bone fractures (Howard et al, 2007; Abel et al, 2008) has shown us the potential.”
BackgroundInfluentialEffects of severe mental illness on bone mineral density and body composition
Hervey, A. M. (2010) · Holmes Museum Of Anthropology (Wichita State University)
Ramasubbu, B. M., Moran, L., Cooney, J. M., & Grieve, P. (2013) · Eurasian Journal of Emergency Medicine · doi:10.5152/jaem.2013.027
“(7) showed an association between prolactin-raising antipsychotic medication and hip fracture.”
BackgroundPhysical Activity and Quality of Life of Outpatients with Schizophrenia
Gomes, E. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/rp0s-8s94
Reyes, C. (2014) · TDX (Tesis Doctorals en Xarxa)
de Paula, F. J. A., Dick‐de‐Paula, I., Kawai, M., & Rosen, C. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00040-6
Maj, M., Ïðåçèäåíò, È., Tasman, A., & Herrman, H. (2011)
Endocrinopathies Due to Psychotropic Agents
Zeshan, M., Basu, S., George, J., Riaz, M., Malik, S., & Imran, N. (2021) · Psychiatric Annals · doi:10.3928/00485713-20210806-01
de Paula, F. J. A., Dick‐de‐Paula, I., Kawai, M., & Rosen, C. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00034-4
Myo-inositol’s Role in Understanding the Pain Perception in Patients with Schizophrenia
Krzyściak, W., Szwajca, M., Karcz, P., Turek, A., Śmierciak, N., Bryll, A., Mazur, P., Chrzan, R. M., Furman, K., Pilecki, M. W., et al. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1005244
Magony, R. E., Brooks, J. S., Schulz, J. M., Pamukoff, D. N., & Thornton, J. S. (2026) · Osteoarthritis and Cartilage Open · doi:10.1016/j.ocarto.2025.100741
“However, the higher prevalence of psychosis may be explained by the inclusion of individuals with hip PTOA in the PTOA group [6], as schizophrenia is associated with an increased risk of hip fractures [40,41].”
Foster, A. E., & King, J. (2026) · Springer eBooks · doi:10.1007/978-3-031-96019-2_4
Metadata
- Authors
- Howard, L., Kirkwood, G., & Leese, M.
- Affiliations
- King's College London (GB)
- Corresponding author
- Howard, Louise
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 2007-02
- Volume
- 190
- Issue
- 2
- Pages
- 129-134
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2166620991
- Cited by
- 158
- References
- 29
- Citations by year
- 2026: 2 · 2024: 6 · 2023: 4 · 2022: 2 · 2021: 8 · 2020: 4 · 2019: 6 · 2018: 6 · 2017: 4 · 2016: 11 · 2015: 5 · 2014: 11 · 2013: 15 · 2012: 15
- FWCI
- 9.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The British Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Keywords
- hip fracture, schizophrenia, bone mineral density, fracture risk, sex differences, fracture prevention, psychiatric patients
- MeSH terms
- Accidental Falls, Female, Hip Fractures, Humans, Male, Prolactin, Risk Factors, Schizophrenia, Antipsychotic Agents, Bone Density, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
